Works matching IS 02683369 AND DT 2010 AND VI 45 AND IP 12

Results: 15

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.

Published in:

2010

By:

Mellon-Reppen, S.;
Ratanatharathorn, V.;
Cronin, S.;
Uberti, J. P.

Publication type:

Letter

Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1749, doi. 10.1038/bmt.2010.47

By:

Schechter, T.;
Macartney, C.;
Finkelstein, Y.;
Gassas, A.;
Husain, M.;
Doyle, J.;
Dupuis, L. L.

Publication type:

Article

Hematopoietic SCT for the treatment of multiple sclerosis.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1671, doi. 10.1038/bmt.2010.168

By:

Atkins, H.

Publication type:

Article

CD34<sup>+</sup> cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1699, doi. 10.1038/bmt.2010.49

By:

Holtan, S. G.;
Hogan, W. J.;
Elliott, M. A.;
Ansell, S. M.;
Inwards, D. J.;
Porrata, L. F.;
Johnston, P. B.;
Micallef, I. N.;
Lacy, M. Q.;
Gastineau, D. A.;
Litzow, M. R.

Publication type:

Article

The impact of novel influenza A (H1N1) after hematopoietic SCT.

Published in:

2010

By:

Patel, P.;
Sweiss, K.;
Shatavi, S.;
Peace, D.;
Clark, N.;
Rondelli, D.

Publication type:

Letter

Prognostic impact of serum ferritin concentration on survival following reduced-intensity conditioned allogeneic haemopoietic SCT.

Published in:

2010

By:

Oakes, R.;
Sood, Nitin;
Pearce, R.;
Swirsky, D.;
Cook, G.;
Gilleece, M.

Publication type:

Letter

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1732, doi. 10.1038/bmt.2010.195

By:

Weng, J. Y.;
Du, X.;
Geng, S. X.;
Peng, Y. W.;
Wang, Z.;
Lu, Z. S.;
Wu, S. J.;
Luo, C. W.;
Guo, R.;
Ling, W.;
Deng, C. X.;
Liao, P. J.;
Xiang, A. P.

Publication type:

Article

Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1704, doi. 10.1038/bmt.2010.50

By:

Jordan, K.;
Wolf, H. H.;
Voigt, W.;
Kegel, T.;
Mueller, L. P.;
Behlendorf, T.;
Sippel, C.;
Arnold, D.;
Schmoll, H. J.

Publication type:

Article

Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1728, doi. 10.1038/bmt.2010.61

By:

Elhasid, R.;
Krivoy, N.;
Rowe, J. M.;
Sprecher, E.;
Efrati, E.

Publication type:

Article

Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1719, doi. 10.1038/bmt.2010.48

By:

Ueda, K.;
Watadani, T.;
Maeda, E.;
Ota, S.;
Kataoka, K.;
Seo, S.;
Kumano, K.;
Hangaishi, A.;
Takahashi, T.;
Imai, Y.;
Ohtomo, K.;
Fukayama, M.;
Nannya, Y.;
Kurokawa, M.

Publication type:

Article

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1682, doi. 10.1038/bmt.2010.34

By:

Yoshimi, A.;
Suzuki, R.;
Atsuta, Y.;
Iida, M.;
Lu, D.-P.;
Tong, W.;
Ghavamzadeh, A.;
Alimoghaddam, K.;
Lie, A. K. W.;
Liang, R.;
Chan, L. L.;
Haipeng, L.;
Tan, P.-L.;
Hwang, W. Y. K.;
Chiou, T.-J.;
Chen, P.-M.;
Van Binh, T.;
Minh, N. N.;
Min, C.-K.;
Hwang, T. J.

Publication type:

Article

UVA (UVA-1) therapy for the treatment of acute GVHD of the skin.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1741, doi. 10.1038/bmt.2010.230

By:

Schlaak, M.;
Schwind, S.;
Wetzig, T.;
Maschke, J.;
Treudler, R.;
Basara, N.;
Lange, T.;
Simon, J. C.;
Niederwieser, D.;
Al-Ali, H. K.

Publication type:

Article

Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1692, doi. 10.1038/bmt.2010.32

By:

Locke, F. L.;
Artz, A.;
Rich, E.;
Zhang, Y.;
van Besien, K.;
Stock, W.

Publication type:

Article

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 12, p. 1710, doi. 10.1038/bmt.2010.38

By:

Blennow, O.;
Remberger, M.;
Klingspor, L.;
Omazic, B.;
Fransson, K.;
Ljungman, P.;
Mattsson, J.;
Ringdén, O.

Publication type:

Article

Sustained CR of refractory aggressive natural killer cell leukemia following unrelated cord blood transplantation.

Published in:

2010

By:

Nishizawa, M.;
Sugino, N.;
Matsui, Y.;
Kaneko, H.;
Watanabe, M.;
Miura, Y.;
Tsudo, M.

Publication type:

Letter